Code usapeptidevendors: 25% off everything at · Purgo Labs

Related brand · disclosed
USA Peptide VendorsIndependent vendor reviews
Purgo Labsusapeptidevendors

Try

Multi-peptide blend · 2 components

CJC-1295 + Ipamorelin: inside the blend

Two-peptide vial with 5mg CJC-1295 (no DAC) and 5mg ipamorelin.

Multi-Peptide BlendsUpdated 2026-11-09

Per-vial contents

Combination untested. Pairs a GHRH-receptor agonist with a ghrelin-receptor agonist, two separate routes to growth hormone release.
Original illustration for CJC-1295 + Ipamorelin (No DAC) research notes: abstract molecular artwork in orange and teal
Original illustration by USA Peptide Vendors; artistic, not a structural model.

What each component does on its own

Evidence level: Components only: no study has tested this combination. All mechanism maps

CJC-1295 + Ipamorelin mechanism diagramEach component's own reported mechanism, side by side. Targets: CJC-1295: GHRH receptor, Ipamorelin: GH secretagogue receptor. : . Effect reported for that component alone: GH release ↑, GH release ↑.CJC-1295 + Ipamorelin mechanism mapEach component's own reported mechanism, side by sideCJC-1295 + Ipamorelin2-component blendCJC-1295: GHRH receptoranterior pituitary somatotrophs [1]Ipamorelin: GH secretagoguereceptorghrelin receptor [2]GH release ↑sustained, healthy adults [3,1]GH release ↑[2]Evidence: Components only: no study has tested this combination. Numbers in brackets referto the cited sources.usapeptidevendors.com · Research Use OnlyCOMPONENT → REPORTED TARGETEFFECT REPORTED FOR THAT COMPONENT ALONE
Each row comes from studies of that peptide on its own. Whether the blend behaves like the sum of its parts has not been studied. Open SVG
  1. Jetté L et al. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats. Endocrinology. 2005;146:3052–3058.
  2. Raun K et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139:552-61.
  3. Teichman SL et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006;91:799–805.

Blend-specific checks

  • Ask for net content per component: CJC-1295 (5mg), Ipamorelin (5mg). A single purity figure for the vial doesn't cover each peptide.

FAQ

What is CJC-1295 + Ipamorelin (No DAC)?

Two-peptide vial with 5mg CJC-1295 (no DAC) and 5mg ipamorelin. Pairs a GHRH-receptor agonist with a ghrelin-receptor agonist, two separate routes to growth hormone release.

What's in CJC-1295 + Ipamorelin (No DAC)?

CJC-1295 5mg, Ipamorelin 5mg. No published study has tested this exact combination; each component's evidence is separate.

Where can US labs buy CJC-1295 + Ipamorelin (No DAC)?

Purgo Labs stocks it as “CJC-1295 / Ipamorln Blend (No Dac)”; code usapeptidevendors takes 25% off at checkout. This page also lists the best-documented second vendor from our 112-vendor directory.

Is research-grade CJC-1295 + Ipamorelin (No DAC) for human use?

No. Vendor material is sold for Research Use Only, not for human or veterinary use.